Free Trial

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AbbVie Inc. stock logo
ABBV
AbbVie
$162.96
-1.0%
$169.58
$130.96
$182.89
$287.77B0.615.48 million shs595,277 shs
The Clorox Company stock logo
CLX
Clorox
$134.63
-0.1%
$145.52
$114.68
$169.14
$16.72B0.441.25 million shs113,418 shs
Chevron Co. stock logo
CVX
Chevron
$161.14
$159.91
$139.62
$171.70
$297.63B1.118.17 million shs846,108 shs
Medtronic plc stock logo
MDT
Medtronic
$84.86
+0.4%
$82.90
$68.84
$91.00
$112.68B0.786.05 million shs606,782 shs
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AbbVie Inc. stock logo
ABBV
AbbVie
-1.08%+2.10%-1.08%-6.33%+13.44%
The Clorox Company stock logo
CLX
Clorox
-0.58%-4.57%-6.07%-11.44%-18.95%
Chevron Co. stock logo
CVX
Chevron
-0.88%-2.02%+0.78%+4.69%+3.87%
Medtronic plc stock logo
MDT
Medtronic
-1.59%+1.23%+6.38%-1.51%-5.35%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AbbVie Inc. stock logo
ABBV
AbbVie
4.5437 of 5 stars
1.43.04.23.93.12.52.5
The Clorox Company stock logo
CLX
Clorox
4.2735 of 5 stars
1.94.04.21.43.31.71.9
Chevron Co. stock logo
CVX
Chevron
4.4671 of 5 stars
3.42.05.00.02.02.51.9
Medtronic plc stock logo
MDT
Medtronic
4.5467 of 5 stars
2.23.03.34.12.62.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AbbVie Inc. stock logo
ABBV
AbbVie
2.79
Moderate Buy$176.148.09% Upside
The Clorox Company stock logo
CLX
Clorox
1.75
Reduce$146.438.76% Upside
Chevron Co. stock logo
CVX
Chevron
2.74
Moderate Buy$186.1015.49% Upside
Medtronic plc stock logo
MDT
Medtronic
2.40
Hold$94.9111.84% Upside

Current Analyst Ratings

Latest CLX, ABBV, CVX, and MDT Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/17/2024
AbbVie Inc. stock logo
ABBV
AbbVie
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOverweight$200.00
5/13/2024
Chevron Co. stock logo
CVX
Chevron
Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$200.00 ➝ $205.00
5/10/2024
Chevron Co. stock logo
CVX
Chevron
Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetHold ➝ Hold$156.00 ➝ $166.00
5/2/2024
The Clorox Company stock logo
CLX
Clorox
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$140.00 ➝ $135.00
5/2/2024
The Clorox Company stock logo
CLX
Clorox
Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderweight ➝ Underweight$136.00 ➝ $132.00
5/1/2024
The Clorox Company stock logo
CLX
Clorox
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$155.00 ➝ $150.00
5/1/2024
The Clorox Company stock logo
CLX
Clorox
UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$164.00 ➝ $159.00
5/1/2024
The Clorox Company stock logo
CLX
Clorox
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$159.00 ➝ $158.00
5/1/2024
The Clorox Company stock logo
CLX
Clorox
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetUnderperform ➝ Underperform$145.00 ➝ $142.00
4/30/2024
Chevron Co. stock logo
CVX
Chevron
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$175.00 ➝ $178.00
4/30/2024
Chevron Co. stock logo
CVX
Chevron
Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$198.00 ➝ $206.00
(Data available from 5/21/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AbbVie Inc. stock logo
ABBV
AbbVie
$54.32B5.30$15.49 per share10.52$5.78 per share28.19
The Clorox Company stock logo
CLX
Clorox
$7.39B2.26$10.53 per share12.79$3.13 per share43.01
Chevron Co. stock logo
CVX
Chevron
$194.65B1.53$22.04 per share7.31$85.78 per share1.88
Medtronic plc stock logo
MDT
Medtronic
$31.23B3.61$7.23 per share11.73$38.83 per share2.19

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AbbVie Inc. stock logo
ABBV
AbbVie
$4.86B$3.3748.3613.492.1011.02%179.47%14.05%7/25/2024 (Estimated)
The Clorox Company stock logo
CLX
Clorox
$149M$1.9369.7621.002.093.33%302.49%12.69%8/7/2024 (Estimated)
Chevron Co. stock logo
CVX
Chevron
$21.37B$10.8714.8210.382.4010.21%14.40%9.00%7/26/2024 (Estimated)
Medtronic plc stock logo
MDT
Medtronic
$3.76B$3.1427.0315.542.8013.00%13.71%7.81%5/23/2024 (Confirmed)

Latest CLX, ABBV, CVX, and MDT Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/23/2024N/A
Medtronic plc stock logo
MDT
Medtronic
$1.45N/A-$1.45N/AN/AN/A  
5/3/2024Q1 24
AbbVie Inc. stock logo
ABBV
AbbVie
$2.26$2.31+$0.05$3.85$11.93 billion$12.31 billion      
4/30/2024Q3 2024
The Clorox Company stock logo
CLX
Clorox
$1.33$1.71+$0.38$3.83$1.87 billion$1.81 billion      
4/26/2024Q1 24
Chevron Co. stock logo
CVX
Chevron
$2.84$2.93+$0.09$2.89$48.42 billion$48.72 billion      

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AbbVie Inc. stock logo
ABBV
AbbVie
$6.203.80%+7.84%183.98%52 Years
The Clorox Company stock logo
CLX
Clorox
$4.803.57%+3.13%248.71%46 Years
Chevron Co. stock logo
CVX
Chevron
$6.524.05%+5.39%59.98%37 Years
Medtronic plc stock logo
MDT
Medtronic
$2.763.25%+6.45%87.90%47 Years

Latest CLX, ABBV, CVX, and MDT Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/26/2024
Chevron Co. stock logo
CVX
Chevron
Quarterly$1.633.93%5/16/20245/17/20246/10/2024
2/28/2024
The Clorox Company stock logo
CLX
Clorox
quarterly$1.203.16%4/23/20244/24/20245/10/2024
3/7/2024
Medtronic plc stock logo
MDT
Medtronic
quarterly$0.693.24%3/21/20243/22/20244/12/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AbbVie Inc. stock logo
ABBV
AbbVie
7.93
0.94
0.83
The Clorox Company stock logo
CLX
Clorox
9.73
0.90
0.53
Chevron Co. stock logo
CVX
Chevron
0.13
1.23
0.93
Medtronic plc stock logo
MDT
Medtronic
0.46
2.30
1.71

Ownership

Institutional Ownership

CompanyInstitutional Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
70.23%
The Clorox Company stock logo
CLX
Clorox
78.53%
Chevron Co. stock logo
CVX
Chevron
72.42%
Medtronic plc stock logo
MDT
Medtronic
82.06%

Insider Ownership

CompanyInsider Ownership
AbbVie Inc. stock logo
ABBV
AbbVie
0.25%
The Clorox Company stock logo
CLX
Clorox
0.51%
Chevron Co. stock logo
CVX
Chevron
0.20%
Medtronic plc stock logo
MDT
Medtronic
0.30%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
AbbVie Inc. stock logo
ABBV
AbbVie
50,0001.77 billion1.76 billionOptionable
The Clorox Company stock logo
CLX
Clorox
8,700124.19 million123.56 millionOptionable
Chevron Co. stock logo
CVX
Chevron
45,6001.85 billion1.84 billionOptionable
Medtronic plc stock logo
MDT
Medtronic
95,0001.33 billion1.32 billionOptionable

CLX, ABBV, CVX, and MDT Headlines

Recent News About These Companies

Medtronic Pulled the Plug on This Device in 2021
Medtronic (NYSE:MDT) Trading Down 1.1%
Medtronic MiniMed 780G recognized as a ‘World-Changing Idea’
Medtronic reports positive results from Affera system trial
Medtronic (NYSE:MDT) Stock Price Down 0.4%
Medtronic (NYSE:MDT) Seems To Use Debt Quite Sensibly
Medtronic Unusual Options Activity

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

AbbVie logo

AbbVie

NYSE:ABBV
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Clorox logo

Clorox

NYSE:CLX
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States. The Household segment provides cat litter products under the Fresh Step and Scoop Away brands; bags and wraps under the Glad brand; and grilling products under the Kingsford brand in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand; natural personal care products under the Burt's Bees brand; and water-filtration products under the Brita brand in the United States. The International segment provides laundry additives; home care products; water-filtration systems; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brands. It sells its products primarily through mass retailers; grocery outlets; warehouse clubs; dollar stores; home hardware centers; drug, pet, and military stores; third-party and owned e-commerce channels; and distributors, as well as a direct sales force The Clorox Company was founded in 1913 and is headquartered in Oakland, California.
Chevron logo

Chevron

NYSE:CVX
Chevron Corporation, through its subsidiaries, engages in the integrated energy and chemicals operations in the United States and internationally. The company operates in two segments, Upstream and Downstream. The Upstream segment is involved in the exploration, development, production, and transportation of crude oil and natural gas; processing, liquefaction, transportation, and regasification of liquefied natural gas; transportation of crude oil through pipelines; transportation, storage, and marketing of natural gas; and carbon capture and storage, as well as a gas-to-liquids plant. The Downstream segment refines crude oil into petroleum products; markets crude oil, refined products, and lubricants; manufactures and markets renewable fuels, commodity petrochemicals, plastics for industrial uses, and fuel and lubricant additives; and transports crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car. The company was formerly known as ChevronTexaco Corporation and changed its name to Chevron Corporation in 2005. Chevron Corporation was founded in 1879 and is headquartered in San Ramon, California.
Medtronic logo

Medtronic

NYSE:MDT
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves; and percutaneous coronary intervention products, percutaneous angioplasty balloons, and products. The company's Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases, as well as products in the fields of minimally invasive gastrointestinal and hepatologic diagnostics and therapies, patient monitoring, airway management and ventilation therapies, and renal disease. Its Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The company's Diabetes Operating Unit segment offers insulin pumps and consumables, continuous glucose monitoring systems, smart insulin pen systems, and consumables and supplies. The company was founded in 1949 and is headquartered in Dublin, Ireland.